<DOC>
	<DOCNO>NCT01571167</DOCNO>
	<brief_summary>The primary purpose study determine effect treatment varenicline ( 1 2 mg daily ) , compare treatment placebo , methamphetamine-induced crave subjective effect methamphetamine-dependent human volunteer .</brief_summary>
	<brief_title>Varenicline Treatment Methamphetamine Dependence</brief_title>
	<detailed_description>This study part effort develop treatment methamphetamine abuse . Varenicline drug change level certain brain chemical may also useful help people stop use methamphetamine . Our goal determine safety effect varenicline ( 1 2 mg , daily , vs. placebo ) use experimental administration methamphetamine , number physical psychological measure ; specifically blood pressure , heart rate , feel take methamphetamine . The secondary purpose determine effect treatment varenicline ( 1 2 mg daily ) , compare treatment placebo , reinforce effect methamphetamine measure methamphetamine self-administration methamphetamine-dependent human volunteer .</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>In order participate study , participant must : 1 . Be Englishspeaking volunteer seek treatment time study 2 . Be 1855 year age 3 . Meet DSMIV TR criterion MA dependence 4 . Must cigarette smoker , define smoke 10 cigarette per day selfreport 5 . Have selfreported history use MA smoke IV route provide least one MApositive urine prior admission 6 . Have vital sign follow : resting pulse 50 90 bpm , blood pressure 105150 mm Hg systolic 4590 mm Hg diastolic ; criterion must meet within 2 day admission 7 . Have hematology chemistry laboratory test within normal ( +/ 10 % ) limit follow exception : ) liver function test ( total bilirubin , ALT , AST , alkaline phosphatase ) &lt; 3 x upper limit normal , b ) kidney function test ( creatinine BUN ) &lt; 2 x upper limit normal 8 . Have baseline EKG demonstrate normal sinus rhythm , normal conduction ( include QTc ) , clinically significant arrhythmias 9 . Have medical history brief physical examination demonstrate clinically significant contraindication study participation , judgment admit physician nurse practitioner principal investigator . Subjects exclude : 1 . Have previous medically adverse reaction METH , include loss consciousness , chest pain , epileptic seizure 2 . Have neurological psychiatric disorder , assess MINI , : episode major depression within past 2 year ; lifetime history schizophrenia , psychotic illness , bipolar illness ; current organic brain disease dementia assess clinical interview ; history current psychiatric disorder would require ongoing treatment would make study compliance difficult ; history suicide attempt within past three month and/or current suicidal ideation/plan ; history psychosis occur absence current METH use 3 . Meet DSMIV criterion abuse/dependence alcohol drug , except nicotine marijuana 4 . Have use methamphetamine intravenous route 5 . Have evidence clinically significant heart disease hypertension , determine physician 6 . Have evidence untreated unstable medical illness include : neuroendocrine , autoimmune , renal , hepatic , active infectious disease 7 . Have HIV currently symptomatic , diagnosis AIDS , currently take antiretroviral medication 8 . Be pregnant nursing . Other female must either unable conceive ( i.e. , surgically sterilize , sterile , postmenopausal ) use reliable form contraception ( e.g. , abstinence , birth control pill , intrauterine device , condom , spermicide ) . All female must provide negative pregnancy urine test study entry , throughout study 9 . Have history asthma , chronic cough wheezing , chronic respiratory illnesses 10 . Currently use alpha beta agonist , theophylline , sympathomimetics 11 . Have make suicide attempt past year 12 . Have illness , condition , use medication , opinion PI and/or admit physician would preclude safe and/or successful completion study . Criteria Discontinuation Following Initiation : 1 . Positive urine drug screen breath test indicate illicit use cocaine , MA , alcohol , opiates , abuse drug deliver part protocol 2 . Inability comply study procedures 3 . Meet discontinuation criterion due exaggerate response MA , describe 4 . Nausea severe enough require treatment . Rationale Subject Selection Criteria : Participants require used MA smoke IV route avoid expose participant route administration produce intensive interoceptive effect . The age criterion select primarily avoid enrol participant undiagnosed cardiovascular disease . Participants active HIV disease exclude avoid potential exacerbation underlie disease ; participant asymptomatic HIV include group high risk MA dependence . Participants asthma ( take asthma medication ) exclude due potential adverse interaction beta agonist medication MA .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Methamphetamine</keyword>
	<keyword>Chantix</keyword>
	<keyword>Varenicline</keyword>
</DOC>